» Articles » PMID: 35463627

Retrospective Observational Study on the Characteristics of Pain and Associated Factors of Breakthrough Pain in Advanced Patients

Overview
Journal Pain Res Manag
Date 2022 Apr 25
PMID 35463627
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aimed to conduct a retrospective observational study to understand the status of characteristics of pain and identify potential variables influencing the clinical presentation of breakthrough cancer pain (BTP) in advanced cancer patients.

Methods: Advanced cancer patients over 18 years of age; diagnosed with cancer of any type and stage III or IV in the palliative care ward with available data were enrolled between 2018 and 2020. Demographic data and pain-related information were collected by using structured electronic extraction form from Hospital Information System (HIS). Patients who had well-controlled background pain with an intensity ≤4 on a 0-10 numerical scale for >12 hours/day, the presence of transient exacerbations of pain with moderate-severe intensity (≧5), and clearly distinguish from background pain were regarded to have suffered BTP. Spearman correlation was conducted to explore the relationship between pain score and demographics characteristics. Factors significant in univariate analysis were included in the multiple regression model to explore independent predictive factors associated with the BTP.

Results: Of 798 advanced cancer patients, the mean age was 56.7 (SD = 11.84) years. Lung cancer (29.95%) was the most common cancer, and pain (93%) was the most common symptom. More than half ( = 428, 53.6%) of the patients experienced BTP. The median number of BTP episodes was 4 (IQR = 2, 7, range: 1-42). The median intensity of BTP was 6 (IQR = 6, 7, range 5-10). Patients with severe background pain or BTP had longer hospital stay and more symptoms. Besides, more severe background pain was related to higher activity of daily living. Intramuscular injection of hydromorphone hydrochloride was the main medication for BTP onset. Younger age, background pain, anorexia, and constipation were independently associated with the presentation of BTP. BTP pain intensity was independently associated with bloating. Symptom numbers were an independent factor and positively associated with BTP episodes.

Conclusions: BTP resulted in poor prognosis, which has a variable presentation depending on interdependent relationships among different characteristics. Good controlling of background pain and assessment of pain-related symptoms are essential for BTP management. BTP should be managed individually, especially the invisible pain among aged patients. Furthermore, BTP-related education and training were still needed.

Citing Articles

A rapid systematic review of breakthrough pain definitions and descriptions.

Greenfield K, Schoth D, Hain R, Bailey S, Mott C, Rajapakse D Br J Pain. 2024; 18(3):215-226.

PMID: 38751563 PMC: 11092936. DOI: 10.1177/20494637231208093.


Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital.

De Moraes A, Erdogan E, Azhar A, Reddy S, Lu Z, Geller J Curr Oncol. 2024; 31(3):1335-1347.

PMID: 38534934 PMC: 10969060. DOI: 10.3390/curroncol31030101.


Trajectories and predictors of high-occurrence pain flares in ambulatory cancer patients on opioids.

Meghani S, Quinn R, Robinson A, Chittams J, Vapiwala N, Naylor M JNCI Cancer Spectr. 2024; 8(1).

PMID: 38268502 PMC: 10880071. DOI: 10.1093/jncics/pkae003.


Breakthrough pain among cancer patients at oncology units in Northern Ethiopia; a multi-center study.

Tekie Y, Nigatu Y, Mekonnen W, Berhe Y Front Oncol. 2024; 13:1248921.

PMID: 38264754 PMC: 10805268. DOI: 10.3389/fonc.2023.1248921.


Multidisciplinary approach, continuous care and opioid management in cancer pain: case series and review of the literature.

Porzio G, Capela A, Giusti R, Lo Bianco F, Moro M, Ravoni G Drugs Context. 2023; 12.

PMID: 37077766 PMC: 10108666. DOI: 10.7573/dic.2022-11-7.


References
1.
Bhatnagar S, Upadhyay S, Mishra S . Prevalence and characteristics of breakthrough pain in patients with head and neck cancer: a cross-sectional study. J Palliat Med. 2010; 13(3):291-5. DOI: 10.1089/jpm.2009.0266. View

2.
Luc-Harkey B, Safran-Norton C, Mandl L, Katz J, Losina E . Associations among knee muscle strength, structural damage, and pain and mobility in individuals with osteoarthritis and symptomatic meniscal tear. BMC Musculoskelet Disord. 2018; 19(1):258. PMC: 6062861. DOI: 10.1186/s12891-018-2182-8. View

3.
Henson L, Maddocks M, Evans C, Davidson M, Hicks S, Higginson I . Palliative Care and the Management of Common Distressing Symptoms in Advanced Cancer: Pain, Breathlessness, Nausea and Vomiting, and Fatigue. J Clin Oncol. 2020; 38(9):905-914. PMC: 7082153. DOI: 10.1200/JCO.19.00470. View

4.
Hjermstad M, Kaasa S, Caraceni A, Loge J, Pedersen T, Faksvag Haugen D . Characteristics of breakthrough cancer pain and its influence on quality of life in an international cohort of patients with cancer. BMJ Support Palliat Care. 2016; 6(3):344-52. DOI: 10.1136/bmjspcare-2015-000887. View

5.
Davies A, Elsner F, Filbet M, Porta-Sales J, Ripamonti C, Santini D . Breakthrough cancer pain (BTcP) management: a review of international and national guidelines. BMJ Support Palliat Care. 2018; 8(3):241-249. DOI: 10.1136/bmjspcare-2017-001467. View